Free Trial

Beximco Pharmaceuticals (LON:BXP) Stock Price Crosses Below Two Hundred Day Moving Average - Should You Sell?

Beximco Pharmaceuticals logo with Medical background

Shares of Beximco Pharmaceuticals Limited (LON:BXP - Get Free Report) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 34.18 ($0.44) and traded as low as GBX 29 ($0.38). Beximco Pharmaceuticals shares last traded at GBX 29 ($0.38), with a volume of 62,338 shares.

Beximco Pharmaceuticals Price Performance

The company has a market capitalization of £129.37 million, a PE ratio of 362.50 and a beta of 0.61. The stock's 50-day moving average is GBX 26.43 and its two-hundred day moving average is GBX 34.15. The company has a current ratio of 1.80, a quick ratio of 0.37 and a debt-to-equity ratio of 14.73.

About Beximco Pharmaceuticals

(Get Free Report)

Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies.

Further Reading

→ Watch this before it gets removed (From Porter & Company) (Ad)

Should you invest $1,000 in Beximco Pharmaceuticals right now?

Before you consider Beximco Pharmaceuticals, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Beximco Pharmaceuticals wasn't on the list.

While Beximco Pharmaceuticals currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

McDonald's Stock on the Verge of a Major Growth Comeback

McDonald's Stock on the Verge of a Major Growth Comeback

Our analysts dive into why McDonald's is a top pick to hold right now, despite recent earnings challenges, and why it could be on the path to a new all-time high.

Related Videos

Top Stocks to Buy, Sell, and Hold Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines